Rossell Biotech Limited - Due diligence report

A 360° intelligence report on Rossell Biotech Limited: trust score, financial health, credit view, compliance, directors, growth and distres…

1996-01-05 Kalkaji, Delhi Active Unlisted Active Compliant
Share
RB Rossell Biotech Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Rossell Biotech Limited — 360° Intelligence Report

Generated from MCA filings & public records
90/100
Trust Score
Low Risk

Rossell Biotech Limited is assessed as Low Risk with a Trust Score of 90/100. Rossell Biotech Limited is an active public limited indian non-government company incorporated in 1996, operating in the Agriculture sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Rossell Biotech Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
90/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
93/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Moderate gearing (D/E 38%).
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 93/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Litigation present in 1 court forum(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ANKIT AGGARWAL 01234567 Director 01/04/2018 6 yrs Approved
KUSHAL AGGARWAL 01234567 Director 01/04/2018 6 yrs Approved
SWATI AGGARWAL 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

As per FY 2018 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 3 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 80
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
Latest year revenue grew 2.1x.
Profit expanded 24% year-on-year.
Asset base grew 0.86 - capacity expansion.
Operating for 30+ years.
Distress signals & risk flags
Outside liabilities up 61% in a year.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence88/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment80/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view92/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
30 Sep 2017
Director ceased
ANKIT AGGARWAL
Director ceased
KUSHAL AGGARWAL
Director ceased
SWATI AGGARWAL
21 Nov 2016
Director ceased
RAM KANWAR BANSAL
Director ceased
SARASWATI DEVI
18 Oct 2016
Director ceased
SUMIT BANSAL
Director ceased
AMIT BANSAL
30 Sep 2016
Director appointed
ANKIT AGGARWAL (Director)
Director appointed
KUSHAL AGGARWAL (Director)
Director appointed
SWATI AGGARWAL (Director)
31 Mar 2016
Share transfer (FY 2016)
906000.00000000 shares to Kanwar Ram
Share transfer (FY 2016)
400000.00000000 shares to Balaji Life Sciences Pvt. Ltd.
Share transfer (FY 2016)
260200.00000000 shares to Saraswati
10

Key Observations

Auto-generated from the data above
Revenue grew 38% over the last 4 financial year(s).
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2018 annual return.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Karandighi Agro Producer Company Limited U01403WB2015PTC207414 Karandghi, West Bengal, India
Gramsathi Agri Tech Producer Company Limited U01100WB2019PTC230373 Birbhum, West Bengal, India
Traditional Small Millets And Herbal Producer Company Limited U01409TZ2018PTC030142 Krishnagiri, Tamil Nadu, India
Jaitu Agrotech Private Limited U01122PB2000PTC023762 Bathinda, Punjab, India
Ankur Kishan Producer Company Limited U01403UP2013PTC059285 Etawa, Uttar Pradesh, India
Idar Stones And Granites Private Limited U14102GJ2006PTC048669 Surat, Gujarat, India
Farmsoul Services Private Limited U01403TG2012PTC083722 Hyderabad, Telangana, India
Omsendriya Farmers Producer Company Limited U01100MH2019PTC320935 Buldhana, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Rossell Biotech Limited before audits and certifications: compliance score 93/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Rossell Biotech Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Rossell Biotech Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 90/100, distress signals and MSME payment-delay disclosures - know whether Rossell Biotech Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Rossell Biotech Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Rossell Biotech Limited an active company?

Rossell Biotech Limited has MCA status “Active” with a compliance score of 93/100 (Low Risk).

Is Rossell Biotech Limited financially healthy?

Rossell Biotech Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Rossell Biotech Limited?

Its overall Trust Score is 90/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Rossell Biotech Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Rossell Biotech Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Rossell Biotech Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 93/100 (Low Risk).

Is it risky to lend to Rossell Biotech Limited?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.